The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 13, 2021
Filed:
Oct. 25, 2019
Applicant:
Redhill Biopharma Ltd., Tel-Aviv, IL;
Inventors:
Reza Fathi, Raleigh, NC (US);
Patrick Laughlin Mclean, Raleigh, NC (US);
Assignee:
RedHill Biopharma Ltd., Tel-Aviv, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4402 (2006.01); A61K 9/20 (2006.01); A61K 31/185 (2006.01); A61K 31/375 (2006.01); A61K 33/08 (2006.01); A61K 9/28 (2006.01); A61P 1/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4402 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2095 (2013.01); A61K 9/28 (2013.01); A61K 9/2893 (2013.01); A61K 31/185 (2013.01); A61K 31/375 (2013.01); A61K 33/08 (2013.01); A61P 1/10 (2018.01);
Abstract
Formulations and methods of manufacturing formulations for use in colonic evacuation are disclosed herein, in an embodiment, a solid dosage formulation includes an intra-granular fraction intermingled with an extra-granular fraction, wherein the intra-granular fraction includes granules comprising at least one osmotic evacuant agent, at least one antacid, and a first pharmaceutically acceptable excipient component, and wherein the extra-granular fraction includes one or more organic acids, a non-metallic lubricating element, and a second pharmaceutically acceptable excipient component.